News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

ORION-8 A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and elevated LDL-C

Study Status:

Closed for enrollment

Contact Information:

(956) 362-2378

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of the study is to evaluate the efficacy, safety and long tolerability of long-term dosing of inclisiran in patient with atherosclerotic cardiovascular disease, hypercholesterolemiaand elevated LDL-C (Bad Cholesterol)


Principal Investigator
Mahesh Changlani, MD
John Rodriguez
The Medicines Company
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram